Everything you need to win Paul Cayer — in one platform.
Who to reach, what to say, and why now on Paul Cayer — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Paul Cayer — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Engrail Therapeutics Appoints Paul Cayer As Chief Financial Officer
PRIVATEAug 08, 2024•almost 2 years ago
Position
Chief Financial Officer
Company
Engrail Therapeutics
Paul Cayer
San DiegoBiotechnologyHealth CareTherapeutics
Description
Engrail Therapeutics announced the appointment of Paul Cayer as the chief financial officer and Saira Ramasastry to the company’s board of directors, with Ms. Ramasastry assuming the position of chair of the audit committee. The company also received a $10 million investment from Foresite Capital in an extension of the Series B financing.
Company Information
Company
Engrail Therapeutics
Location
San Diego, California, United States
About
Engrail Therapeutics is a precision neuroscience company focused on developing transformational therapies to improve the lives of patients with neuropsychiatric and neurodevelopmental diseases.
San DiegoBiotechnologyHealth CareTherapeutics